Can chimerism explain breast/ovarian cancers in BRCA non-carriers from BRCA-positive families?

about

Can chimerism explain breast/ovarian cancers in BRCA non-carriers from BRCA-positive families?

Item

http://www.wikidata.org/entity/Q52586080

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Can chimerism explain breast/o ...... s from BRCA-positive families?

@en

Can chimerism explain breast/o ...... s from BRCA-positive families?

@nl

type

Item

label

Can chimerism explain breast/o ...... s from BRCA-positive families?

@en

Can chimerism explain breast/o ...... s from BRCA-positive families?

@nl

prefLabel

Can chimerism explain breast/o ...... s from BRCA-positive families?

@en

Can chimerism explain breast/o ...... s from BRCA-positive families?

@nl

P1476

Can chimerism explain breast/o ...... s from BRCA-positive families?

@en

P2093

Jacob Rotmensch

http://www.w3.org/2001/XMLSchema#string

Kelly Burgess

http://www.w3.org/2001/XMLSchema#string

Lela Buckingham

http://www.w3.org/2001/XMLSchema#string

Lydia Usha

http://www.w3.org/2001/XMLSchema#string

Melody Cobleigh

http://www.w3.org/2001/XMLSchema#string

P2860

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies

BRCA1 mediates ligand-independent transcriptional repression of the estrogen receptor

The impact of a panel of 18 SNPs on breast cancer risk in women attending a UK familial screening clinic: a case-control study.

Cancer susceptibility and the functions of BRCA1 and BRCA2

Fetal microchimerism in women with breast cancer

Characterization of BRCA1 and BRCA2 mutations in a large United States sample

Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium

The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews

Population-based study of the risk of second primary contralateral breast cancer associated with carrying a mutation in BRCA1 or BRCA2.

Prophylactic mastectomy in BRCA1/2 mutation carriers and women at risk of hereditary breast cancer: long-term experiences at the Rotterdam Family Cancer Clinic.

P304

e0195497

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0195497

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Rachel Mitchell

P577

2018-04-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29659587

http://www.w3.org/2001/XMLSchema#string

P921

ovarian cancer

P932

5901986

http://www.w3.org/2001/XMLSchema#string